Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Several groups demonstrated that PERM1 is a positive regulator of mitochondrial bioenergetics in the heart. However, discrepant results have emerged with regard to whether PERM1 loss-of-function affect cardiac contractility. Here we present data from a retrospective study collecting echocardiography data from all knockout (-KO) mice and their wildtype (WT) littermates used for various molecular biological experiments in our lab between April of 2022 and September of 2023. This yielded an atypically large number of subjects per group, 84 WT mice and 88 -KO mice. We analyzed Echo-derived parameters of left ventricular (LV) systolic function. The ejection fraction (EF) was 65.43±7.13 in WT vs. 53.98±8.80 in P-KO yielding p < 0.00000000000000004 using unpaired t-test. Other parameters which reached statistically significant difference between WT and -KO (at p < 0.05) included LV fractional shortening, LV diastolic and systolic diameters, LV anterior and posterior systolic wall thickness, LV posterior wall systolic thickening, stroke volume, and cardiac output. Changes caused by constitutive -KO can be conceptualized as reduced contractility partially compensated by increased LV circumference. This study provides a strong evidence that -KO causes a specific remodeling of cardiac contractility and provides retrospective power analysis which can be useful for future prospective studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12363925PMC
http://dx.doi.org/10.21203/rs.3.rs-6204170/v1DOI Listing

Publication Analysis

Top Keywords

retrospective study
8
cardiac contractility
8
-ko mice
8
-ko
5
analysis systolic
4
cardiac
4
systolic cardiac
4
cardiac function
4
function perm1-knockout
4
mice
4

Similar Publications

Aims: To assess self-reported practices and knowledge of nurses and prescribers (i.e., physicians and nurse practitioners) on intravenous fluid therapy, and to evaluate how this is documented through a clinical documentation review.

View Article and Find Full Text PDF

Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare Costs.

Drug Alcohol Rev

September 2025

The Prescription Drug Misuse Education and Research (PREMIER) Center, University of Houston, Houston, Texas, USA.

Introduction: Buprenorphine is effective for opioid use disorder (OUD), yet adherence remains suboptimal. This study aimed to identify adherence trajectories, explore their predictors, and assess their association with opioid overdose risk and healthcare costs.

Methods: A retrospective cohort study was conducted using the Merative MarketScan Commercial Database, which includes a nationally representative sample of individuals with private, employer-sponsored health insurance in the United States.

View Article and Find Full Text PDF

Objectives: Acute pyelonephritis (APN) is a common diagnosis among patients presenting to the Emergency Department (ED). It is treated by empiric antibiotics within the ED. With a rise in antimicrobial resistance globally, it is unknown whether patients are being managed with empiric antibiotics that are appropriate for the causative organisms of APN.

View Article and Find Full Text PDF

In-Flight Deterioration Occurs Early in Aeromedical Trauma Patients.

Emerg Med Australas

October 2025

Australian Centre for Health Services Innovation, School of Public Health & Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.

Reliably defining the risk of adverse in-flight events in aeromedical trauma patients could enable more informed pre-departure treatment and guide central asset allocation to achieve better system-level outcomes. Unfortunately, the current literature base specifically examining the in-flight period is sparse. Flight duration is often considered a proxy for the risk of in-flight deterioration; however, there is limited data to support this commonly held assumption.

View Article and Find Full Text PDF

Aims: Chronic ocular diseases such as age-related macular degeneration (AMD) are leading causes of vision loss in older adults. While sodium-glucose co-transporter 2 inhibitors (SGLT2i) are widely prescribed in the management of type 2 diabetes mellitus (T2DM), their effects on ocular disease risk remain largely unknown.

Materials And Methods: This retrospective cohort study evaluated the association between SGLT2i use and the risk of AMD and other age-related ocular conditions in adults aged ≥60 with T2DM, using a target trial emulation framework based on the TriNetX global health research network (2013-2025).

View Article and Find Full Text PDF